Barclays Maintains Underweight on Definitive Healthcare, Lowers Price Target to $3
Benzinga Newsdesk 1 year ago
NewsPrice TargetAnalyst Ratings
Barclays analyst Saket Kalia maintains Definitive Healthcare (NASDAQ:DH) with a Underweight and lowers the price target from $4 to $3.
Barclays analyst Saket Kalia maintains Definitive Healthcare (NASDAQ:DH) with a Underweight and lowers the price target from $4 to $3.